Comparison of Disease Status and Outcomes of Patients With Psoriatic Arthritis (PSA) Receiving Adalimumab or Etanercept Monotherapy in the United States (US)
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.900
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV